Why Tanzania, and why now

Tanzania imported an estimated US$358.8 million in pharmaceutical products in 2024, with India supplying roughly US$205.3 million of that — over half the total, from a single country of origin.¹ With a population above 68 million and a healthcare system that remains heavily import-dependent, Tanzania is one of the largest single-country opportunities covered in this series.

Two things distinguish TMDA from its regional neighbours. First, in 2018 TMDA became the first regulatory authority in Africa to attain WHO Global Benchmarking Tool Maturity Level 3 (ML3) — a stable, well-functioning regulatory system — and retained that status after a full WHO reassessment in 2023.⁵ That is a materially more mature starting point than the “Level 2 moving toward Level 3” position described for Kenya’s PPB in our companion guide, and it shows up directly in TMDA’s willingness to publish exact day-counts for almost every service it offers, not just headline figures.

Second, TMDA finalized new Guidelines on Regulatory Reliance for Marketing Authorization of Human Medicinal Products in July 2025, and issued a public notice on 30 June 2026 confirming the pathway is live: applications for products already authorized by a Reference Regulatory Authority are evaluated within 90 working days of acceptance — against 180 working days on the standard track.³ That is the newest, most exporter-relevant regulatory development in this entire series, and as of this writing it isn’t reflected in most third-party guides to the Tanzanian market.

The sequence: premises → product → permit

This is where Tanzania differs most sharply from Kenya and Uganda, and where generic guides tend to blur the picture. TMDA does not run “product registration” as a single track alongside a separate importer-licensing track — it runs them sequentially. Your Tanzanian partner’s premises must be registered before TMDA will progress a product application tied to that premises, and the import permit only becomes available after both are done.

For manufacturers, TMDA also inspects the plant itself: once samples are submitted and pass testing, the Products Registration Certificate is issued. For a foreign manufacturer’s site specifically, TMDA’s overseas GMP inspection carries its own standard — a report and compliance certificate within 45 working days of the inspection.² Dealers and importers who don’t manufacture receive a Business Licence at the premises-registration stage instead.

Why the sequencing matters more here than elsewhere in this series

In Kenya and Uganda, an exporter can realistically start the product dossier and the local-partner relationship in parallel with only moderate risk. In Tanzania, a product application submitted before your partner’s premises is registered simply has nowhere to attach — TMDA’s own process description ties product registration to an already-registered premises.⁶ Get your Tanzanian LTR’s premises registered first, or run it hard in parallel from day one; treating it as an afterthought is the single most common reason Tanzania timelines blow past the published standard.

Who does what: manufacturer vs. Tanzanian LTR

TMDA maintains a public list of recognised Local Technical Representatives (LTRs) — the same concept used in Kenya and Uganda, under the same name.⁷ For an India-based exporter, the split looks like this:

Where a WHO-GMP contract manufacturer changes the math: if you’re a brand owner or distributor without your own approved plant, sourcing from a WHO-GMP third-party manufacturing partner means the CPP, GMP certificate, site master file and stability data arrive as a ready package — and, if that plant also holds WHO-PQ or SRA approval, it is what qualifies the file for TMDA’s 90-day reliance track rather than the 180-day standard track. See our third-party manufacturing for African markets guide for how that arrangement is typically scoped.

Registration, step by step

Every figure below is TMDA’s own published standard from its Clients’ Service Charter (4th Edition, 2020) and its July 2026 reliance-pathway notice — not a third-party estimate.

1. Appoint your LTR and register premises

   Your Tanzanian LTR’s manufacturing, storage or distribution premises is inspected (5–7 working days) and, if compliant, issued a Premises Registration Certificate and Business Permit (3 working days).²

2. Dossier compilation

   Build the full CTD across Modules 1–5 in the EAC-harmonised ICH format, first codified by TMDA in January 2015.⁹ Consistency between modules is the most common trigger for query cycles later.

3. Application submission

   Submit through TMDA’s online system via your LTR, tied to the now-registered premises, and pay statutory fees via GEPG.

4. Screening & validation

   TMDA checks the application is complete before it enters evaluation. Incomplete files are returned at this stage.

5. Evaluation

   Standard track for an imported medicinal product: 180 working days. Reliance track for WHO-PQ / SRA / other RRA-authorized products: 90 working days from acceptance.^2,3 Query-response evaluation on the standard track: 80 working days.²

6. Overseas GMP inspection, where required

   TMDA’s standard for sending the inspection report and issuing the GMP compliance certificate for an imported product’s manufacturing site: 45 working days each.²

7. Marketing Authorization issued

   Valid five years from first issue. Renewal must be filed at least three months before expiry.⁴

8. Import permit, per shipment

   Once the product is registered, TMDA’s own standard for issuing an import permit for a registered product is 1 working day — rising to 7 days for a special permit.²

The CTD dossier — and what “complete” really means

TMDA’s Guidelines on Submission of Documentation for Registration of Human Pharmaceutical Products, first published January 2015, adopt the ICH Common Technical Document (CTD) format across five modules — the same EAC-harmonised structure covered in our Kenya PPB guide, with only Module 1 (local administrative content) changing per country.⁹

Interactive · Dossier readiness check

Fees & the registration planner

TMDA’s fees are set under the Tanzania Medicines and Medical Devices (Fees and Charges) Regulations and are payable in Tanzanian shillings or US$ equivalent, processed through the Government e-Payment Gateway (GEPG) against a Control Number issued on a TMDA Proforma Invoice — accepted at Citibank, CRDB, NMB and NBC.⁸ We could not source an official, published USD figure specifically for imported human-medicine Marketing Authorization within this build; treat any number you’re quoted elsewhere as unverified until your LTR confirms it against the current Fourth Schedule.

Interactive · TMDA registration planner

Two realistic timelines, not one

TMDA publishes exact working-day standards for almost every step, which makes Tanzania one of the more plannable East African markets in this series — provided the premises-first sequence is respected.

What blows the timeline: filing the product application before the premises registration is complete, inconsistent CTD modules, and slow responses to TMDA queries during the 80-day evaluation window on the standard track.²

EAC-MRH: register once, expand across East Africa

Tanzania was one of the five founding states when the East African Community Medicines Regulatory Harmonization (EAC-MRH) programme launched on 30 March 2012, alongside Kenya, Uganda, Rwanda and Burundi — the same framework referenced in our PPB Kenya guide.¹⁰ TMDA maintains a dedicated East African Community Mutual Recognition Procedures (EAC-MRP) function, and the July 2025 reliance guidelines explicitly extend the same logic to WHO-PQ and SRA-authorized products, not only EAC joint assessments.³

The practical play: register in Kenya first, then reuse the CTD core for Uganda (NDA) and Tanzania (TMDA) — adjusting only local administrative content and, in Tanzania’s case, sequencing the premises registration ahead of the product filing. This is the same logic behind our pharmaceutical export to Africa approach.

Common delay triggers — and how to avoid them

• Filing the product before the premises is registered. TMDA’s product-registration process assumes a registered premises is already in place — this is the single most Tanzania-specific mistake in this series.⁶
• Weak or missing stability data. Ensure data supports the claimed shelf life under the correct climatic zone before filing.
• Inconsistency between CTD modules. Figures or claims that don’t reconcile across Modules 1–5 generate queries during the 80-day response-evaluation window.²
• An unrecognised or absent GMP status. A site TMDA hasn’t assessed, with no WHO-PQ / SRA record to rely on, means the standard 180-day track and a fresh 45-day overseas inspection instead of the 90-day reliance track.^2,3
• Treating the LTR as a formality. The representative is a legal correspondence role, not a mailbox — and in Tanzania, also the party who must get your premises registered before anything else can move.
• Registering the product but not the import route. Import permits move fast (1 working day) once a product is registered, but only once — not before.²

Sequencing multiple products: once premises registration is done, lead with the SKUs that have the clearest commercial case. Registering a whole catalogue at once multiplies query load without multiplying early revenue.

TMDA Tanzania registration — frequently asked questions